Browsing by Author Palafox-Sanchez, C.A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 11 to 30 of 34 < previous   next >
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphismsNavarro-Hernandez, R.E.; Oregon-Romero, E.; Mercado, M.V.-D.; Rangel-Villalobos, H.; Palafox-Sanchez, C.A.; Muoz-Valle, J.F.--
Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphismsNavarro-Hernandez, R.E.; Oregon-Romero, E.; Mercado, M.V.-D.; Rangel-Villalobos, H.; Palafox-Sanchez, C.A.; Muoz-Valle, J.F.--
FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndromeTrevino-Talavera, B.A.; Palafox-Sanchez, C.A.; Munoz-Valle, J.F.; Orozco-Barocio, G.; Navarro-Hernandez, R.E.; Mercado, M.V.-D.; Garcia de la Torre, I.; Oregon-Romero, E.--
FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sj�gren's syndromeTrevino-Talavera, B.A.; Palafox-Sanchez, C.A.; Munoz-Valle, J.F.; Orozco-Barocio, G.; Navarro-Hernandez, R.E.; Mercado, M.V.-D.; Garcia de la Torre, I.; Oregon-Romero, E.--
High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosusVazquez-Del Mercado, M.; Palafox-Sanchez, C.A.; Munoz-Valle, J.F.; Orozco-Barocio, G.; Oregon-Romero, E.; Navarro-Hernandez, R.E.; Salazar-Paramo, M.; Armendariz-Borunda, J.; Gamez-Nava, J.I.; Gonzalez-Lopez, L.; Chan, J.Y.F.; Chan, E.K.L.; Satoh, M.--
High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosusVazquez-Del Mercado, M.; Palafox-Sanchez, C.A.; Munoz-Valle, J.F.; Orozco-Barocio, G.; Oregon-Romero, E.; Navarro-Hernandez, R.E.; Salazar-Paramo, M.; Armendariz-Borunda, J.; Gamez-Nava, J.I.; Gonzalez-Lopez, L.; Chan, J.Y.F.; Chan, E.K.L.; Satoh, M.--
Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritisLlamas-Covarrubias, M.A.; Valle, Y.; Bucala, R.; Navarro-Hernandez, R.E.; Palafox-Sanchez, C.A.; Padilla-Gutierrez, J.R.; Parra-Rojas, I.; Bernard-Medina, A.G.; Reyes-Castillo, Z.; Munoz-Valle, J.F.--
Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritisLlamas-Covarrubias, M.A.; Valle, Y.; Bucala, R.; Navarro-Hernandez, R.E.; Palafox-Sanchez, C.A.; Padilla-Gutierrez, J.R.; Parra-Rojas, I.; Bernard-Medina, A.G.; Reyes-Castillo, Z.; Munoz-Valle, J.F.--
Macrophage migration inhibitory factor: Association of -794 CATT5-8 and -173 G&gt;C polymorphisms with TNF-? in systemic lupus erythematosusDe la Cruz-Mosso, U.; Bucala, R.; Palafox-Sanchez, C.A.; Parra-Rojas, I.; Padilla-Gutierrez, J.R.; Pereira-Suarez, A.L.; Rangel-Villalobos, H.; Vazquez-Villamar, M.; Angel-Chavez, L.I.; Munoz-Valle, J.F.--
Macrophage migration inhibitory factor: Association of -794 CATT5-8 and -173 G&gt;C polymorphisms with TNF-α in systemic lupus erythematosusDe la Cruz-Mosso, U.; Bucala, R.; Palafox-Sanchez, C.A.; Parra-Rojas, I.; Padilla-Gutierrez, J.R.; Pereira-Suarez, A.L.; Rangel-Villalobos, H.; Vazquez-Villamar, M.; Angel-Chavez, L.I.; Munoz-Valle, J.F.--
Oxidized Low-Density Lipoprotein/?2-Glycoprotein I Complexes and Autoantibodies to oxLig-1/?2-Glycoprotein I in Patients with Systemic Lupns Erythematosus and Antiphospholipid SyndromeLopez, D.; Garcia-Valladares, I.; Palafox-Sanchez, C.A.; De La Torre, I.G.; Kobayashi, K.; Matsuura, E.; Lopez, L.R.--
Oxidized Low-Density Lipoprotein/β2-Glycoprotein I Complexes and Autoantibodies to oxLig-1/β2-Glycoprotein I in Patients with Systemic Lupns Erythematosus and Antiphospholipid SyndromeLopez, D.; Garcia-Valladares, I.; Palafox-Sanchez, C.A.; De La Torre, I.G.; Kobayashi, K.; Matsuura, E.; Lopez, L.R.--
Plasma enhanced modification of Xanthan and its use in Chitosan/xanthan HydrogelsTorres-Carrillo, N.; Torres-Carrillo, N.M.; Martinez-Bonilla, G.E.; Vazquez-Del Mercado, M.; Palafox-Sanchez, C.A.; Oregon-Romero, E.; Bernard-Medina, A.G.; Rangel-Villalobos, H.; Munoz-Valle, J.F.--
Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritisTorres-Carrillo, N.; Torres-Carrillo, N.M.; Martinez-Bonilla, G.E.; Vazquez-Del Mercado, M.; Palafox-Sanchez, C.A.; Oregon-Romero, E.; Bernard-Medina, A.G.; Rangel-Villalobos, H.; Munoz-Valle, J.F.--
Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: Association with clinical variablesPadilla-Gutierrez, J.R.; Palafox-Sanchez, C.A.; Valle, Y.; Orozco-Barocio, G.; Oregon-Romero, E.; Vazquez-Del Mercado, M.; Rangel-Villalobos, H.; Llamas-Covarrubias, M.A.; Munoz-Valle, J.F.--
Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: Association with clinical variablesPadilla-Gutierrez, J.R.; Palafox-Sanchez, C.A.; Valle, Y.; Orozco-Barocio, G.; Oregon-Romero, E.; Vazquez-Del Mercado, M.; Rangel-Villalobos, H.; Llamas-Covarrubias, M.A.; Munoz-Valle, J.F.--
Polymorphisms and functional haplotype in PADI4: Further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican populationGuzman-Guzman, I.P.; Reyes-Castillo, Z.; Munoz-Barrios, S.; Ruiz-Noa, Y.; Martinez-Bonilla, G.E.; Parra-Rojas, I.; Palafox-Sanchez, C.A.; Munoz-Valle, J.F.--
Polymorphisms and functional haplotype in PADI4: Further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican populationGuzman-Guzman, I.P.; Reyes-Castillo, Z.; Munoz-Barrios, S.; Ruiz-Noa, Y.; Martinez-Bonilla, G.E.; Parra-Rojas, I.; Palafox-Sanchez, C.A.; Munoz-Valle, J.F.--
The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western MexicoTorres-Carrillo, N.M.; Ruiz-Noa, Y.; Martinez-Bonilla, G.E.; Leyva-Torres, S.D.; Torres-Carrillo, N.; Palafox-Sanchez, C.A.; Navarro-Hernandez, R.E.; Rangel-Villalobos, H.; Oregon-Romero, E.; Munoz-Valle, J.F.--
The adenylyl cyclase Rv2212 modifies the proteome and infectivity of Mycobacterium bovis BCGTorres-Carrillo, N.M.; Ruiz-Noa, Y.; Martinez-Bonilla, G.E.; Leyva-Torres, S.D.; Torres-Carrillo, N.; Palafox-Sanchez, C.A.; Navarro-Hernandez, R.E.; Rangel-Villalobos, H.; Oregon-Romero, E.; Munoz-Valle, J.F.--